08:03 AM EDT, 10/31/2025 (MT Newswires) -- AbbVie ( ABBV ) reported Q3 adjusted earnings Friday of $1.86 per diluted share, down from $3.00 a year earlier.

Analysts polled by FactSet expected $1.77.

Net revenue for the quarter ended Sept. 30 was $15.78 billion, compared with $14.46 billion a year earlier.

Analysts surveyed by FactSet expected $15.59 billion.

For 2025, AbbVie ( ABBV ) said it now expects adjusted EPS in the range of $10.61 to $10.65, compared with its prior outlook of between $10.38 and $10.58. Analysts polled by FactSet expect $10.51.

Additionally, the company said its board increased the quarterly cash dividend to $1.73 from $1.64 per share, beginning with the dividend to be paid on Feb. 17 to shareholders of record as of Jan. 16.